A familiar diabetes drug reduced tumors faster and prolonged remission in mice longer than chemotherapy alone by targeting cancer stem cells, Harvard Medical School researchers reported in Cancer Research
. The American Association for Cancer Research hosted a news briefing about the results of this study on Monday, Sept. 14, 2009. Read the press release
and listen to the teleconference below for more information on the study and panelists.
Download* the mp3 of the press briefing (8.74 MB, 38 minutes and 11 seconds)
*On a PC, right mouse click on the "Download" link and select "Save link as..." in Firefox or "Save Target as..." in Internet Explorer.
Page updated: Sept. 22, 2009